扫码下载APP

您的位置

学者详情
孙小单

孙小单

吉林省肿瘤医院

8

H指数

15

论文数

171

被引数

H指数、论文数、被引数仅支持在APP上查看和修改扫描二维码即可下载APP

孙小单,现任职于吉林省肿瘤医院,曾任职于中国医科大学机构,个人H指数为8,累计发表论文15篇,论文总被引数累计171次,主要研究方向涵盖医学、药理学,毒理学和药剂学等领域,在Oxidative Medicine and Cellular Longevity、Cancers和Frontiers in Cell and Developmental Biology顶级期刊累计发表4次

访客XXX

可下载论论APP查看访客

本人可编辑资料

学者资料仅支持在APP上编辑扫描二维码即可编辑

  • 发表期刊
  • 资讯动态
  • 发表论文
  • 引用关系
新型酪氨酸激酶抑制剂阿帕替尼通过Nrf2/HO-1通路促进卵巢癌细胞ROS依赖性凋亡和自噬

Apatinib, a novel tyrosine kinase inhibitor, promotes ROS-dependent apoptosis and autophagy via the Nrf2/HO-1 pathway in Ovarian cancer cells

中国医科大学沈阳分校

2020

被引数:24

Oxidative Medicine and Cellular Longevity

李庆昌

c-Myc靶向HDAC3,通过组蛋白去乙酰化抑制N型小细胞肺癌中NKG2DL表达和先天免疫反应

c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation

吉林省肿瘤医院

2022

被引数:6

Cancers

Cheng, Ying

C-Myc,HDAC3,Histone deacetylation,Innate immune response,NKG2DL,SCLC
Deltex家族泛素E3连接酶在发育和疾病中的功能和分子机制

Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease

中国医科大学沈阳分校

2021

被引数:13

Frontiers in Cell and Developmental Biology

刘臻

Deltex family proteins,post-translational modification,protein homeostasis,ubiquitin code,ubiquitin E3 ligase,ubiquitination
甲状腺癌中与免疫细胞浸润模式相关的预后相关标志ATP结合盒转运体的鉴定和验证

Identification and Validation of Prognostic Related Hallmark ATP-Binding Cassette Transporters Associated With Immune Cell Infiltration Patterns in Thyroid Carcinoma

中国医科大学沈阳分校

2022

被引数:1

Frontiers in Oncology

刘臻

immune cell infiltration,prognosis,thyroid carcinoma,immunomodulation,ATP-binding cassette transporters
广泛期小细胞肺癌一线免疫治疗相关总生存率替代终点的考虑

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

吉林省肿瘤医院

2021

被引数:3

Frontiers in Oncology

Cheng, Ying

immunotherapy,restricted mean survival time (RMST),small-cell lung cancer,surrogate endpoints,survival
SIRT5通过调节Nrf2/HO-1通路以ROS依赖的方式抑制dna损伤,从而促进卵巢癌对顺铂的耐药性

SIRT5 promotes cisplatin resistance in ovarian cancer by suppressing dna damage in a ROS-dependent manner via regulation of the Nrf2/HO-1 pathway

中国医科大学沈阳分校

2019

被引数:60

Frontiers in Oncology

李庆昌

Drug resistance,Nrf2/HO-1,Ovarian cancer,Reactive oxygen species,SIRT5

引用关系明细仅支持在APP查看扫描二维码即可下载

全部资讯信息仅支持在APP上查看扫描二维码即可下载APP